Recording that elusive rhythm

Krahn, Andrew D.; Klein, George J.; Yee, Raymond; Skanes, Allan C.
November 1999
CMAJ: Canadian Medical Association Journal;11/30/99, Vol. 161 Issue 11, p1424
Academic Journal
Discusses the use of the implantable loop recorder, a cardiac monitor which is implanted in patients with recurrent unexplained syncope to provide up to 14 months of cardiac monitoring. Technology used; History; Promise; Problems; Prospects; Vignette.


Related Articles

  • Medtronic launches CareLink Express remote monitoring. Kimball, Robert // Medical Device Daily;8/15/2012, Vol. 16 Issue 158, p1 

    The article reports on the launch of the CareLink Express Service in the U.S. by Medtronic. Clinicians in healthcare facilities can quickly obtain data on the status of Medtronic implanted cardiac devices with the service, which is a remote monitoring system. The article also describes the...

  • Complete Atrioventricular Block Presenting With Syncope Caused by Severe Hypothyroidism. Sang-Hoon Seol; Doo-Il Kim; Bo-Min Park; Dong-Kie Kim; Pil-Sang Song; Ki-Hun Kim; Han-Young Jin; Jeong-Sook Seo; Jae-Sik Jang; Tae-Hyun Yang; Dae-Kyeong Kim; Dong-Soo Kim // Cardiology Research;2012, Vol. 3 Issue 5, p239 

    A 75-year-old man was admitted to our hospital with syncope. Electrocardiogram showed complete atrioventricular block and bradycardia with the minimum heart rate of 22 beats/ min. There was a possible indication for temporary cardiac pacemaker implantation. Laboratory data on admission revealed...

  • Pacemaker therapy did not reduce recurrent vasovagal syncope.  // ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p77 

    This article discusses whether pacemaker therapy reduces the risk for recurrent syncope in patients with vasovagal syncope. 100 patients of more than 19 years of age who had a history of recurrent vasovagal syncope with 6 episodes of syncope ever or a 3 episodes in the past 2 years, and a...

  • Pacemaker therapy did not reduce recurrent vasovagal syncope: COMMENTARY. Oral, Hakan; Eagle, Kirn A. // ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p77 

    In a well-designed study, researchers S.J. Connolly and colleagues addresses whether dual-chamber pacing (DDD)with a rate-drop function decreases the incidence of recurrent syncope in patients with severe vasovagal syncope. This study is unique because all patients received a dual-chamber...

  • PRODUCT BRIEFS.  // Diagnostics & Imaging Week;4/2/2009, Vol. 12 Issue 13, p10 

    This section offers news briefs on the clinical diagnostics and diagnostic imaging sectors as of April 2009. The AspirinWorks Test, which determines the effect of aspirin on platelets, is now available in the Wichita, Kansas, area. Biotronik announced that global launch of its Biotronik Home...

  • Biotronik gets CE mark for remote patient monitoring technology.  // Medical Device Daily;10/19/2009, Vol. 13 Issue 201, p1 

    The article reports on the Communauté Européenne (CE) mark received by Biotronik, a manufacturer of implantable cardiac devices, for its remote patient monitoring technology called Biotronik Home Monitoring. The remote patient monitoring device is for patients with implantable cardiac...

  • New automated system measures device safety. FORD, OMAR // Medical Device Daily;11/15/2010, Vol. 14 Issue 222, p1 

    The article reports on the creation of a computer-automated safety surveillance system designed to monitor the safety of approved medical products, specifically cardiovascular devices, by Frederic Resnic of Brigham and Women's Hospital and Harvard Medical School. A cohort study that made use of...

  • Sorin receives CE mark for Paradym RF ICDs and CRT-D.  // Medical Device Daily;5/6/2011, Vol. 15 Issue 88, p1 

    The article reports that a CE mark approval has been given to the Sorin Group for its Paradym RF1 family of implantable cardioverter-defibrillator (ICDs) and cardiac resynchronization therapy for defibrillators (CRT-D). It is noted that these devices automatically adjust for customized therapy...

  • Champion PMA falls over trial violations, real-world use issues. McCarty, Mark // Medical Device Daily;12/12/2011, Vol. 15 Issue 236, p1 

    The article discusses the vote against the CardioEMS Champion heart monitoring system by the U.S. Food and Drug Administration (FDA) in terms of its risk-benefit profile due to protocol violations during the pivotal device trials. The Champion is an implantable hemodynamic sensor that picks up...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics